Innovation for Your Health
 

All news from Hamburg
and Schleswig-Holstein

06/11/2019

Evotec receives $ 23.8 m grant to join the global fight against tuberculosis

Evotec SE announced that the company has entered into a five-year partnership with the Bill & Melinda Gates Foundation to discover new treatment regimens that better address tuberculosis (“TB”), a...

05/22/2019

Evotec acuires Just Biotherapeutics

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”), for up to $ 90 m including potential performance-based earn-out...

04/25/2019

Eppendorf with worldwide setting program

The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company...

04/15/2019

Breaking ground for the Innovation Centre

The mayor of Hamburg, Dr. Peter Tschentscher, symbolically broke the ground together with his deputy, the Senator for Science Katharina Fegebank, the Chairman of DESY’s Board of Directors, Dr. Helmut...

04/15/2019

Evotec and Indivumed announce collaboration for colorectal cancer

Evotec SE and Indivumed GmbH announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer (“CRC”). The...

04/10/2019

New Leibniz Science Campus in Hamburg: InterACt

Hamburg has acquired a Leibniz Science Campus: InterACt—which stands for “integrated analysis of pathogen-induced compartments”—is a cooperative project to strengthen connections between The Heinrich...

04/05/2019

Eppendorf AG increases sales and earnings in 2018 and accelerates organic growth

2018 was a very good fiscal year for the Eppendorf Group. The globally operating Hamburg-based life sciences company increased its Group sales by 5.6% (organic growth in local currencies +8.2%) to...

03/27/2019

Collaboration in immuno-oncology: Evotec and The Mark Foundation for Cancer Research

Evotec AG and The Mark Foundation for Cancer Research today announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics in oncology. The...

03/11/2019

EIB supports sustainable growth in Schleswig-Holstein

The European Investment Bank (EIB) has provided the Schleswig-Holstein Investment Bank (IB.SH) with EUR 200 million to finance low-interest loans in support of sustainable growth in...

03/11/2019

Sakura Pascarelli appointed scientific director at European XFEL

The Italian physicist Dr. Sakura Pascarelli will be the new scientific director at European XFEL. Pascarelli will join European XFEL on 1 September from the European Synchrotron Radiation Facility,...

© Copyright Life Science Nord e.V.

All rights reserved. Especially reprint, incorporation in online services, internet and amplification using data vehicles like CD-Rom, DVD-ROM etc. even in extracts require written permission by Life Science Nord e.V. Life Science NOrd e.V. is not responsible for content of external links and and foreign contents.

In case you would like to use our newsletter via email as a free-of-charge and effective PR tool, please send us your company news that we eill publish in the following issue. Profit from this communication platform, make new contacts and take care of existing ones.

Contact

Simone Hauck
PR & Communications Manager

P +49.40.471 96-423
e-mail

Partner

  • Desitin

Content loading failure